Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-27

Clinical Trial Update: UVA1 Light for Scleroderma and Similar Conditions [NA]

View source ↗

Summary

A University of Michigan-sponsored UVA1 light therapy trial for scleroderma and related conditions (keloid, scars, granuloma annulare, acne keloidalis nuchae) w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Keloid, Scleroderma | NA | Status: TERMINATED